In this study, we also developed prediction models using circulating levels of IL-1β, IL-6, and IL-17 as biomarkers to distinguish obese children with NAFLD from simple obese children. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.